Allurion Technologies, INC Schedule 13D activist filings

RTW Investments, LP and Roderick Wong, M.D. have filed an amendment to their Schedule 13D, detailing a recent share exchange and warrant agreement with Allurion Technologies, Inc.

RTW Investments, LP and its affiliates updated their beneficial ownership in Allurion Technologies, Inc. to 39.4% following an increase in the issuer's outstanding shares.

Allurion Technologies, Inc. announced a debt-for-equity exchange and a private placement, strengthening its financial position and governance with RTW Investments.

RTW Investments and its affiliated funds converted $5.0 million in principal amount of notes into 1,492,539 shares of Allurion Technologies, Inc. common stock, increasing their beneficial ownership.

RTW Investments, a significant shareholder in Allurion Technologies, has increased its beneficial ownership to 34.1% by converting $5.0 million in notes into 1,492,539 common shares, following an amendment to their note purchase agreement.

RTW Investments, LP and its affiliates have increased their beneficial ownership in Allurion Technologies, Inc. to 17.6% of the common stock outstanding.

RTW Investments, LP and its affiliated funds, along with Roderick Wong, M.D., have filed an amended Schedule 13D, reporting a combined beneficial ownership of 21.9% of Allurion Technologies, Inc.'s common stock.

RTW Investments, LP and Roderick Wong, M.D. have increased their beneficial ownership in Allurion Technologies, Inc. to 29.6% through a $2.5 million private placement and hold an option for an additional $10 million investment.

RTW Investments, LP and Roderick Wong, M.D. have increased their beneficial ownership in Allurion Technologies, Inc. to 9.99% and secured additional board representation following an Omnibus Amendment to existing financing agreements.